Science Explorer Back to mapMap

Most cited papers from Kaiser-Franz-Josef-Spital

What are the most cited papers from Kaiser-Franz-Josef-Spital?

The most cited paper from Kaiser-Franz-Josef-Spital is "Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer" (Jan B. Vermorken, Ricard Mesı́a, Fernando Rivera et al., 2008), with 3,762 citations. Next come "Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis" (2,304) and "Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer" (1,726).

Showing 50 of 60 papers. Every paper with more than 202 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer Jan B. Vermorken, Ricard Mesı́a, Fernando Rivera et al. · New England Journal of Medicine Open access 10 Sep 2008 3,762
2 Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis Uri A. Liberman, Stuart R. Weiss, Johann Bröll et al. · New England Journal of Medicine 30 Nov 1995 2,304
3 Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer Jan Baptist Vermorken, Éva Remenár, Carla van Herpen et al. · New England Journal of Medicine Open access 24 Oct 2007 1,726
4 Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer Claus Michael Rödel, Peter Martus, Thomas Papadoupolos et al. · Journal of Clinical Oncology 26 Oct 2005 1,227
5 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines Johannes Alfred Witjes, Éva Compérat, Nigel C. Cowan et al. · European Urology 12 Dec 2013 1,014
6 EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction Christian Gratzke, Alexander Bachmann, A. Descazeaud et al. · European Urology 19 Jan 2015 1,012
7 Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen Eric Lancaster, Meizan Lai, Xiaoyu Peng et al. · The Lancet Neurology Open access 4 Dec 2009 927
8 Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density Ian R. Reid et al. · New England Journal of Medicine Open access 28 Feb 2002 877
9 A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update Jean-Nicolas Cornu, Sascha Ahyai, Alexander Bachmann et al. · European Urology Review 25 Jun 2014 818
10 Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986 Maria De Santis, Joaquim Bellmunt, Graham M. Mead et al. · Journal of Clinical Oncology Open access 13 Dec 2011 787
11 Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial Martin J. van den Bent, Alain Carpentier, Alba Ariela Brandes et al. · Journal of Clinical Oncology 16 Jun 2006 750
12 Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines Arnulf Stenzl, Nigel C. Cowan, Maria De Santis et al. · European Urology May 2011 679
13 The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer Arnulf Stenzl, Nigel C. Cowan, Maria De Santis et al. · European Urology 14 Jan 2009 644
14 European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I S. Krege et al. · European Urology 14 Jan 2008 618
15 Chemotherapy‐induced neuropathy Anthony J. Windebank, Wolfgang Grisold · Journal of the Peripheral Nervous System Mar 2008 614
16 Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance Jorg Reinier Oddens, Maurizio A. Brausi, Richard J Sylvester et al. · European Urology 2 Nov 2012 523
17 Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis Carsten Bokemeyer, Craig R. Nichols, J P Droz et al. · Journal of Clinical Oncology Apr 2002 508
18 Guidelines on management of low‐grade gliomas: report of an EFNS–EANO* Task Force Riccardo Soffietti, Brigitta G. Baumert, Lorenzo Bello et al. · European Journal of Neurology Open access 16 Aug 2010 506
19 Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention Wolfgang Grisold, Guido Cavaletti, Anthony J. Windebank · Neuro-Oncology Open access Sep 2012 495
20 Association between ultrasound measurements of muscle thickness, pennation angle, echogenicity and skeletal muscle strength in the elderly Eva-Maria Strasser, Thomas Draskovits, Markus Praschak et al. · AGE Open access 2 Mar 2013 447
21 Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes Johannes R. Lemke et al. · Nature Genetics 11 Aug 2013 446
22 Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder Richard J Sylvester, Maurizio A. Brausi, Wim J. Kirkels et al. · European Urology Open access 19 Dec 2009 439
23 Human recombinant soluble ACE2 in severe COVID-19 Alexander Zoufaly, Marko Poglitsch, Judith Helene Aberle et al. · The Lancet Respiratory Medicine Open access 24 Sep 2020 432
24 Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial Cora Nanette Sternberg et al. · The Lancet Oncology 11 Dec 2014 390
25 Refining the prognostic impact of functional mitral regurgitation in chronic heart failure Georg Goliasch, Philipp E Bartko, Noémi Pávó et al. · European Heart Journal 28 Jun 2017 359
26 Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study Klaus‐Peter Dieckmann et al. · Journal of Clinical Oncology Open access 15 Mar 2019 354
27 Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review Stephan Madersbacher, Natalie Sampson, Zoran Čulig · Gerontology Review 2019 353
28 Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up Joaquim Bellmunt, Anna Orsola, Jeffrey Jia Jun Leow et al. · Annals of Oncology Open access 6 Aug 2014 340
29 EFNS guidelines on the diagnosis and management of orthostatic hypotension Heinz Lahrmann, Pietro Cortelli, Max Josef Hilz et al. · European Journal of Neurology Open access 17 Jul 2006 336
30 Rickettsia africae,a Tick-Borne Pathogen in Travelers to Sub-Saharan Africa Didier Raoult, Pierre‐Edouard Fournier, Florence Fenollar et al. · New England Journal of Medicine 17 May 2001 326
31 Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015 Silke Gillessen et al. · Annals of Oncology Open access 4 Jun 2015 324
32 Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer J. Beyer et al. · Annals of Oncology Open access 14 Nov 2012 323
33 Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose Chemotherapy Johannes W. Drach, Jutta Ackermann, Elke Fritz et al. · Blood Aug 1998 322
34 Laryngeal Recurrent Nerve Injury in Surgery for Benign Thyroid Diseases Martin Hermann, Gunter Alk, Rudolf Roka et al. · Annals of Surgery Open access Feb 2002 318
35 Maintenance Bacillus Calmette-Guerin for Ta T1 Bladder Tumors Is Not Associated with Increased Toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial Adrian P.M. van der Meijden, Richard J Sylvester, Wim Oosterlinck et al. · European Urology 31 Jul 2003 306
36 Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt Bernhard Angermayr, M Cejna, F Karnel et al. · Gut Open access 9 May 2003 294
37 The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings Guido Cavaletti et al. · Annals of Oncology Open access 22 Aug 2012 292
38 Incidence and outcome of weaning from mechanical ventilation according to new categories G-C. Funk, Shilo H. Anders, M.-K. Breyer et al. · European Respiratory Journal Open access 18 Jun 2009 278
39 Reoperation, Myocardial Infarction and Mortality after Transurethral and Open Prostatectomy: A Nation-Wide, Long-Term Analysis of 23,123 Cases Stephan Madersbacher, Jakob E. Lackner, Clemens Brössner et al. · European Urology 5 Jan 2005 276
40 Neuromonitoring in Thyroid Surgery Martin Hermann, Christa Hellebart, Michael Freissmuth · Annals of Surgery Open access 22 Jun 2004 266
41 Prevalence of self‐reported neuropathic pain and impact on quality of life: a prospective representative survey Burkhard Gustorff, Thomas Ernst Dorner, Rudolf Likar et al. · Acta Anaesthesiologica Scandinavica Nov 2007 266
42 Gastric Interleukin‐8 and IgA IL‐8 Autoantibodies in Helicobacter pylori Infection J. E. Crabtree, P. Peichl, J I Wyatt et al. · Scandinavian Journal of Immunology 1993 263
43 A consensus review on the development of palliative care for patients with chronic and progressive neurological disease David J. Oliver, Gian Domenico Borasio, Augusto Tommaso Caraceni et al. · European Journal of Neurology Open access Oct 2015 262
44 Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 Alexandra Mihaela Popa et al. · Science Translational Medicine Open access 23 Nov 2020 261
45 Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1–3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations Sumanta Kumar Pal et al. · Cancer Discovery Open access 30 May 2018 260
46 Peginterferon Alfa-2a and Ribavirin for 24 Weeks in Hepatitis C Type 1 and 4 Patients With Rapid Virological Response Péter Ferenci, Hermann Laferl, Thomas–Matthias Scherzer et al. · Gastroenterology 18 Apr 2008 253
47 Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Joaquim Bellmunt, Anna Orsola, Thomas Wiegel et al. · Annals of Oncology Open access Sep 2011 250
48 Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis Gabriela León Cobo, Manfred Hecking, Friedrich K. Port et al. · Clinical Science Jun 2016 241
49 Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study Frederike Lentz, Anne Drescher, Andreas Lindauer et al. · Anti-Cancer Drugs 5 Jan 2009 241
50 Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients Robert Königsberg, Eva Obermayr, Giovanna Bises et al. · Acta Oncologica Open access 24 Jan 2011 240

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.